171 related articles for article (PubMed ID: 2132409)
1. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
Casiglia D; Giardina E; Scarantino G; Triolo G
Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
[TBL] [Abstract][Full Text] [Related]
3. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
Muratsugu M; Makino M; Kohda H; Sekiya C
Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
[No Abstract] [Full Text] [Related]
4. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus.
Triolo G; Giardina E; Seddio G; Terrizzi C
Boll Ist Sieroter Milan; 1987; 66(2):116-9. PubMed ID: 3311077
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
Lutz HU; Fumia S
Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-phospholipid (cardiolipin, phosphatidylserine) antibodies in the serum of patients with non insulin-dependent (type 2) diabetes mellitus and macroangiopathy. Coexistence of anti-platelet reactivity.
Triolo G; Giardina E; Scarantino G; Seddio G; Bompiani G
Diabetes Res; 1989 Feb; 10(2):63-7. PubMed ID: 2743710
[TBL] [Abstract][Full Text] [Related]
7. IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus.
Triolo G; Giardina E; Rinaldi A; Bompiani GD
Clin Immunol Immunopathol; 1984 Feb; 30(2):169-77. PubMed ID: 6692599
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
[TBL] [Abstract][Full Text] [Related]
9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
10. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
Triolo G; Giardina E; Bompiani GD
J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
[TBL] [Abstract][Full Text] [Related]
11. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
[TBL] [Abstract][Full Text] [Related]
13. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
[TBL] [Abstract][Full Text] [Related]
14. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
Kauffmann RH; de Rooy-Dijk HH; Klein F; Lafeber GJ; Cats A; van Es LA
Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
[TBL] [Abstract][Full Text] [Related]
15. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
[TBL] [Abstract][Full Text] [Related]
16. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
Lorenz KJ; Süsal C; Opelz G; Maier H
Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
[TBL] [Abstract][Full Text] [Related]
17. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
Chen QY; Rowley MJ; Mackay IR
Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
[TBL] [Abstract][Full Text] [Related]
18. [Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus].
Zhaboedov GD; Kopaenko AI
Vestn Oftalmol; 2005; 121(6):29-31. PubMed ID: 16405060
[TBL] [Abstract][Full Text] [Related]
19. Normal human sera contain antibodies directed at Fab of IgA.
Jackson S; Montgomery RI; Mestecky J; Czerkinsky C
J Immunol; 1987 Apr; 138(7):2244-8. PubMed ID: 3494062
[TBL] [Abstract][Full Text] [Related]
20. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
